tiprankstipranks
Ping An Healthcare and Technology Company Limited (HK:1833)
:1833
Hong Kong Market
1833
Ping An Healthcare and Technology Company
RESEARCH TOOLSreports
Want to see HK:1833 full AI Analyst Report?

Ping An Healthcare and Technology Company (1833) Stock Forecast & Price Target

17 Followers
See the Price Targets and Ratings of:

1833 Analyst Ratings

Strong Buy
5Ratings
Strong Buy
4 Buy
1 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Ping
An Healthcare and Technology Company
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1833 Stock 12 Month Forecast

Average Price Target

HK$17.17
▲(42.47% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Ping An Healthcare and Technology Company in the last 3 months. The average price target is HK$17.17 with a high forecast of HK$23.88 and a low forecast of HK$14.20. The average price target represents a 42.47% change from the last price of HK$12.05.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"HK$5","24":"HK$24","9.75":"HK$9.75","14.5":"HK$14.5","19.25":"HK$19.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":23.88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$23.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.168,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$17.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$14.20</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,9.75,14.5,19.25,24],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.98,8.280000000000001,9.58,10.879999999999999,12.18,13.48,14.78,16.08,17.38,18.68,19.979999999999997,21.279999999999998,22.58,{"y":23.88,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.98,7.763692307692308,8.547384615384615,9.331076923076923,10.11476923076923,10.898461538461538,11.682153846153845,12.465846153846154,13.24953846153846,14.03323076923077,14.816923076923075,15.600615384615384,16.384307692307694,{"y":17.168,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.98,7.535384615384616,8.090769230769231,8.646153846153846,9.201538461538462,9.756923076923076,10.31230769230769,10.867692307692307,11.423076923076923,11.978461538461538,12.533846153846152,13.089230769230769,13.644615384615383,{"y":14.2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.77,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.7,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.31,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.74,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.08,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.03,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.12,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.2,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.75,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.12,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.98,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$23.88Average Price TargetHK$17.17Lowest Price TargetHK$14.20
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on HK:1833
Unknown Analyst
CICC
Not Ranked
CICC
HK$14.2
Buy
17.84%
Upside
Reiterated
05/15/26
CICC Reaffirms Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)
UOB Kay Hian Analyst forecast on HK:1833
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$17.5→HK$14.5
Buy
20.33%
Upside
Reiterated
04/24/26
Ping An Healthcare and Technology Company (PANHF) Receives a Buy from UOB Kay Hian
Morgan Stanley Analyst forecast on HK:1833
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
HK$16.8
Hold
39.42%
Upside
Reiterated
04/23/26
Ping An Healthcare and Technology Company (PANHF) Receives a Hold from Morgan Stanley
GF Securities Analyst forecast on HK:1833
Unknown Analyst
GF Securities
Not Ranked
GF Securities
HK$19.65→HK$16.46
Buy
36.60%
Upside
Reiterated
04/07/26
GF Securities Remains a Buy on Ping An Healthcare and Technology Company (PANHF)
China Renaissance Analyst forecast on HK:1833
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$23.88
Buy
98.17%
Upside
Reiterated
04/04/26
China Renaissance Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)
Huatai Securities Analyst forecast on HK:1833
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$15.9
Buy
31.95%
Upside
Reiterated
03/28/26
Huatai Securities Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)
CLSA Analyst forecast on HK:1833
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$19
Buy
57.68%
Upside
Reiterated
03/26/26
CLSA Keeps Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)
UBS Analyst forecast on HK:1833
Unknown Analyst
UBS
Not Ranked
UBS
HK$14.5
Hold
20.33%
Upside
Reiterated
03/25/26
UBS Remains a Hold on Ping An Healthcare and Technology Company (PANHF)
Citi Analyst forecast on HK:1833
Unknown Analyst
Citi
Not Ranked
Citi
HK$18
Buy
49.38%
Upside
Reiterated
03/25/26
Ping An Healthcare and Technology Company (PANHF) Receives a Buy from Citi
Jefferies Analyst forecast on HK:1833
Cui Cui
Jefferies
Jefferies
HK$12.4
Hold
2.90%
Upside
Reiterated
03/25/26
Jefferies Reaffirms Their Hold Rating on Ping An Healthcare and Technology Company (PANHF)
Citic Securities Analyst forecast on HK:1833
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$21
Buy
74.27%
Upside
Reiterated
11/25/25
SPDB Analyst forecast on HK:1833
Unknown Analyst
SPDB
Not Ranked
SPDB
HK$14
Sell
16.18%
Upside
Reiterated
10/28/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on HK:1833
Unknown Analyst
CICC
Not Ranked
CICC
HK$14.2
Buy
17.84%
Upside
Reiterated
05/15/26
CICC Reaffirms Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)
UOB Kay Hian Analyst forecast on HK:1833
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$17.5→HK$14.5
Buy
20.33%
Upside
Reiterated
04/24/26
Ping An Healthcare and Technology Company (PANHF) Receives a Buy from UOB Kay Hian
Morgan Stanley Analyst forecast on HK:1833
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
HK$16.8
Hold
39.42%
Upside
Reiterated
04/23/26
Ping An Healthcare and Technology Company (PANHF) Receives a Hold from Morgan Stanley
GF Securities Analyst forecast on HK:1833
Unknown Analyst
GF Securities
Not Ranked
GF Securities
HK$19.65→HK$16.46
Buy
36.60%
Upside
Reiterated
04/07/26
GF Securities Remains a Buy on Ping An Healthcare and Technology Company (PANHF)
China Renaissance Analyst forecast on HK:1833
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$23.88
Buy
98.17%
Upside
Reiterated
04/04/26
China Renaissance Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)
Huatai Securities Analyst forecast on HK:1833
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$15.9
Buy
31.95%
Upside
Reiterated
03/28/26
Huatai Securities Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)
CLSA Analyst forecast on HK:1833
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$19
Buy
57.68%
Upside
Reiterated
03/26/26
CLSA Keeps Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)
UBS Analyst forecast on HK:1833
Unknown Analyst
UBS
Not Ranked
UBS
HK$14.5
Hold
20.33%
Upside
Reiterated
03/25/26
UBS Remains a Hold on Ping An Healthcare and Technology Company (PANHF)
Citi Analyst forecast on HK:1833
Unknown Analyst
Citi
Not Ranked
Citi
HK$18
Buy
49.38%
Upside
Reiterated
03/25/26
Ping An Healthcare and Technology Company (PANHF) Receives a Buy from Citi
Jefferies Analyst forecast on HK:1833
Cui Cui
Jefferies
Jefferies
HK$12.4
Hold
2.90%
Upside
Reiterated
03/25/26
Jefferies Reaffirms Their Hold Rating on Ping An Healthcare and Technology Company (PANHF)
Citic Securities Analyst forecast on HK:1833
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$21
Buy
74.27%
Upside
Reiterated
11/25/25
SPDB Analyst forecast on HK:1833
Unknown Analyst
SPDB
Not Ranked
SPDB
HK$14
Sell
16.18%
Upside
Reiterated
10/28/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1833 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
2
2
1
0
Buy
5
7
6
3
1
Hold
2
3
3
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
12
11
5
1
In the current month, 1833 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1833 average Analyst price target in the past 3 months is 17.17.
Each month's total comprises the sum of three months' worth of ratings.

1833 Financial Forecast

1833 Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

1833 Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

1833 Stock Forecast FAQ

What is HK:1833’s average 12-month price target, according to analysts?
Based on analyst ratings, Ping An Healthcare and Technology Company Limited’s 12-month average price target is 17.17.
    What is HK:1833’s upside potential, based on the analysts’ average price target?
    Ping An Healthcare and Technology Company Limited has 42.47% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Ping An Healthcare and Technology Company Limited a Buy, Sell or Hold?
          Ping An Healthcare and Technology Company Limited has a consensus rating of Strong Buy, which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Ping An Healthcare and Technology Company Limited’s share price target?
            The average share price target for Ping An Healthcare and Technology Company Limited is 17.17. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$23.88 ,and the lowest forecast is HK$14.20. The average share price target represents 42.47% Increase from the current price of HK$12.05.
              What do analysts say about Ping An Healthcare and Technology Company Limited?
              Ping An Healthcare and Technology Company Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of Ping An Healthcare and Technology Company Limited?
                To buy shares of HK:1833, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.